FDA Letter API

DoctorVicks.com

Letter data

Company
DoctorVicks.com
Recipient
DoctorVicks.com | United States
Issue date
2018-02-02
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
512642
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER DoctorVicks.com MARCS-CMS 512642 — February 02, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: DoctorVicks.com United States Issuing Office: United States Office of Human and Animal Food Operations East Division 1 February 2, 2018 DoctorVicks.com Attn: Sholom Levitin 2112 59th St. Brooklyn, NY 11204 28500 Nutwood Lane Wickliffe, OH 44092 Dear Mr. Levitin: The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter NYK-2017-08 dated April 17, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Catherine Beer Director, Compliance Branch Office of Human and Animal Food Operations East Division 1 Content current as of: 02/02/2018